NIH Director Jay Bhattacharya and FDA Chief Marty Makary Take Office Amid Controversy

On his first day as the new director of the National Institutes of Health (NIH), Dr. Jay Bhattacharya has announced plans to compile grants related to misinformation and censorship, signaling a focus on these critical issues. Bhattacharya, known for his controversial views on public health policies, aims to address the impact of misinformation on public health research and outcomes.

Simultaneously, the Senate has confirmed Dr. Marty Makary as the new head of the Food and Drug Administration (FDA). Makary, who served as an advisor to former President Donald Trump, has been a vocal advocate for the abortion pill mifepristone, which has been at the center of recent legal battles. His appointment is seen as a move to strengthen the FDA's stance on reproductive health issues.

The appointments of Bhattacharya and Makary come at a time when both misinformation and reproductive rights are hotly debated topics in the U.S. Their roles will be pivotal in shaping federal health policies and addressing the challenges posed by these issues.

• FDA
• Jay Bhattacharya
• Marty Makary
• NIH